Publications by authors named "Ilene Galinsky"

Claim this Profile
A
Avapritinib versus midostaurin or cladribine in advanced systemic mastocytosis: A retrospective real-world external control study.
Andreas Reiter, Jason Gotlib, Iván Álvarez-Twose, Deepti H Radia, Johannes Lübke, Ilene A Galinsky

Leuk Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemia.
Emma-Jayne Minihane, Leah Krotee, Jason Wu, Lindsey Thornton, Geoffrey Fell, Ilene Galinsky

bioRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Care Optimization for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm Receiving Tagraxofusp.
Karolina Faysman, Joelle Rubin, Amber Lubas, Taylor Kujawa, Gabriel Hinojosa, Ilene A Galinsky

J Adv Pract Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen.
Shai Shimony, Hari S Raman, Yael Flamand, Julia Keating, Jonathan D Paolino, Ilene Galinsky

Blood Cancer J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia.
Andrew A Lane, Jacqueline S Garcia, Evangeline G Raulston, Jada L Garzon, Ilene Galinsky

Blood Adv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings.
Jacqueline S Garcia, Yael Flamand, Livius Penter, Michael Keng, Benjamin K Tomlinson, Ilene Galinsky

Blood· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates.
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Ilene Galinsky

Clin Cancer Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis.
Andreas Reiter, Jason Gotlib, Iván Álvarez-Twose, Deepti H Radia, Johannes Lübke, Ilene A Galinsky

Leukemia· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma.
Ellen Weisberg, Basudev Chowdhury, Chengcheng Meng, Abigail E Case, Wei Ni, Ilene Galinsky

Blood Cancer J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Management of the Venetoclax-Treated Patient in Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia.
Matthew Waggoner, John Katsetos, Emilee Thomas, Ilene Galinsky, Heather Fox

J Adv Pract Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial.
Vincent T Ho, Haesook T Kim, Jennifer Brock, Ilene Galinsky, Heather Daley

Blood Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasms.
Debra Van Egeren, Baransel Kamaz, Shichen Liu, Maximilian Nguyen, Christopher R Reilly, Ilene Galinsky

Exp Hematol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial.
Richard A Larson, Sumithra J Mandrekar, Lucas J Huebner, Ben L Sanford, Kristina Laumann, Ilene Galinsky

Leukemia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists.
Valerie Relias, Ali McBride, Matthew J Newman, Shilpa Paul, Seyyedeh Saneeymehri, Ilene Galinsky

J Oncol Pharm Pract· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms.
Debra Van Egeren, Javier Escabi, Maximilian Nguyen, Shichen Liu, Christopher R Reilly, Ilene Galinsky

Cell Stem Cell· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor.
Blandine Roux, Camille Vaganay, Jesse D Vargas, Gabriela Alexe, Chaima Benaksas, Ilene Galinsky

Sci Transl Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Midostaurin: Nursing Perspectives on Managing Treatment and Adverse Events in Patients With FLT3 Mutation-Positive Acute Myeloid Leukemia and Advanced Systemic Mastocytosis.
Ilene Galinsky, Melanie Coleman, Lenn Fechter

Clin J Oncol Nurs· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy.
Vera Mugoni, Riccardo Panella, Giulia Cheloni, Ming Chen, Olga Pozdnyakova, Ilene Galinsky

Cell Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity.
Peter van Galen, Volker Hovestadt, Marc H Wadsworth Ii, Travis K Hughes, Gabriel K Griffin, Ilene Galinsky

Cell· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia.
Andrew M Brunner, Donna S Neuberg, Seth A Wander, Hossein Sadrzadeh, Karen K Ballen, Ilene Galinsky

Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma.
Susanne H Baumeister, Joana Murad, Lillian Werner, Heather Daley, Helene Trebeden-Negre, Ilene Galinsky

Cancer Immunol Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropathology of a Case With Fatal CAR T-Cell-Associated Cerebral Edema.
Matthew Torre, Isaac H Solomon, Claire L Sutherland, Sarah Nikiforow, Daniel J DeAngelo, Ilene A Galinsky

J Neuropathol Exp Neurol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms.
Ofir Wolach, Rob S Sellar, Kimberly Martinod, Deya Cherpokova, Marie McConkey, Ilene Galinsky

Sci Transl Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia.
Florence F Wagner, Lina Benajiba, Arthur J Campbell, Michel Weïwer, Joshua R Sacher, Ilene Galinsky

Sci Transl Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the Advanced Practice Provider in Clinical Trials: Contributions to the Management of Patients Receiving Inotuzumab Ozogamicin.
Mary Alma Welch, Joanne C Ryan, Ilene Ann Galinsky

J Adv Pract Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis